Hostname: page-component-8448b6f56d-t5pn6 Total loading time: 0 Render date: 2024-04-16T08:16:20.407Z Has data issue: false hasContentIssue false
  • English
  • Français

A health policy analysis of pharmacotherapy for major depressive disorder in Europe and the Americas

Published online by Cambridge University Press:  16 April 2020

Steven R. Arikian ,
Thomas R. Einarson ,
Julian P. Casciano  and
John J. Doyle
Steven R. Arikian
Affiliation:
The = Analytica Group. Ltd, Scarsdale, NY Columbia School of Public Health, New York, NY, USA
Thomas R. Einarson
Affiliation:
Faculty of Pharmacy, The University of Toronto, Ontario, Canada
Julian P. Casciano
Affiliation:
The = Analytica Group. Ltd, Scarsdale, NY
John J. Doyle
Affiliation:
The = Analytica Group. Ltd, Scarsdale, NY Columbia School of Public Health, New York, NY, USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposia
Information
European Psychiatry , Volume 13 , Issue S4: Standards of psychiatry - 9th Congress of Association of European Psychiatrists , 1998 , pp. 137s
Copyright
Copyright © European Psychiatric Association 1998
Submit a response

Comments

No Comments have been published for this article.